Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neocortical explants is seen only with the beta-1, not with the beta-2 subtype

Neurochem Res. 1995 May;20(5):579-86. doi: 10.1007/BF01694539.

Abstract

The presence and time-course of beta-adrenoceptor density in cultured explants of neocortex obtained from 6-day-old rat pups were investigated using a [125I]ICYP binding assay. A delayed, but more pronounced, increase in the receptor expression was observed as compared to the situation previously described in vivo. These changes only occurred for the beta 1-subtype of the receptor, whereas the beta 2-subtype binding remained constant up to 3 weeks in vitro. The delay of beta 1-adrenoceptor expression may be due to the incomplete presence of the proper maturational input, and the late enhancement of receptor expression to upregulation related to the absence in vitro of noradrenergic input. Decreased beta-adrenoceptor levels could be induced by chronic treatment of the beta-agonist isoproterenol (1 microM) introduced either for 3 or 13 days. Again, changes in density were found only for the beta 1-adrenoceptor binding sites. There is no reduction of receptor density following return to control conditions for 10 days after a 3-day treatment with isoproterenol, demonstrating the ability of this model to attain its final receptor density notwithstanding the developmental insult.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / growth & development
  • Cerebral Cortex / metabolism
  • Culture Techniques
  • Down-Regulation / drug effects
  • Isoproterenol / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta-1 / drug effects*
  • Receptors, Adrenergic, beta-1 / metabolism
  • Receptors, Adrenergic, beta-2 / drug effects*
  • Receptors, Adrenergic, beta-2 / metabolism

Substances

  • Receptors, Adrenergic, beta-1
  • Receptors, Adrenergic, beta-2
  • Isoproterenol